Get started

Stockpicks

LOAC Announces Signing of Definitive Merger AgreementLongevity Acquisition Corporation Announces Signing of Definitive Merger Agreement 4D pharma's Live Biotherapeutic Products (LBPs) are orally delivered single strains of bacteria that are naturally found in the healthy human gut. The Company has six clinical programs At the effective time of the merger, each of LOAC's ordinary shares issued and outstanding prior to the effective time of the merger will be automatically converted into the right to receive certain per share merger consideration, and each warrant to purchase LOAC's ordinary shares and right to receive LOAC's ordinary shares that is outstanding immediately prior to the effective time of the merger will be assumed by 4D pharma and automatically converted into a warrant to purchase ordinary shares of 4D pharma and a right to receive ordinary shares of 4D pharma, payable in 4D pharma ADSs, respectively. www.prnewswire.com
L
by AlenCiken
Are all-time highs in the cart?The range trade from November 13 has been like watching paint dry until today. You can see the overall decrease in the net volume amplitudes- a sign of little movement in either direction. With todays big move we now sit a little above the mid point of the range but where is amzn heading next? As long as the broader market uptrend remains intact amzn could be heading back toward all time highs. The reference point to watch is Fridays low 3169. If that holds the trade is still on and the highs of the range is our initial target
NASDAQ:AMZN
by IngenuityTrading
AST & Science LLC to Become Public Company via NPA spac companyAST & Science LLC to Become Public Company Through Combination with New Providence Acquisition Corp. (NASDAQ: NPA, NPAUU and NPAWW) - AST & Science LLC ("AST SpaceMobile") is building the first and only space-based cellular broadband network accessible directly by standard mobile phones. - Combined company to have an estimated post-transaction enterprise value of $1.4 billion and will become listed on the NASDAQ under the ticker symbol "ASTS" following expected transaction close in the first quarter of 2021. Expected to have an equity value of approximately $1.8 billion at closing, or 1.4 times calendar year 2024's estimated EBITDA of approximately $1 billion. The company will have no debt on the balance sheet at closing. - Transaction to provide up to $462 million in gross proceeds, comprised of New Providence Acquisition Corp.'s $232 million of cash held in trust (assuming no redemptions) and a $230 million fully committed common stock PIPE at $10.00 per share, including investments from Rakuten, Vodafone, American Tower, UBS O'Connor and a broad base of financial institutions - AST SpaceMobile LLC shareholders Vodafone, Rakuten, American Tower, and Cisneros will increase their equity holding through participation in the PIPE financing in support of AST SpaceMobile's transition into the publicly listed company. Backed by an extensive IP and patent portfolio, AST SpaceMobile will uniquely address the $1 trillion global mobile wireless services market finance.yahoo.com
N
by AlenCiken
Cano Health to Become Publicly Traded via Merger with JWSCano Health, a Leading Value-Based Care Delivery Platform for Seniors, to Become Publicly Traded via Merger with Jaws Acquisition Corp. - Transaction values Cano Health at an enterprise value of $4.4 billion and is expected to provide up to $1.49 billion in cash proceeds, including a fully committed PIPE of $800 million - PIPE led by $50 million investment from Barry Sternlicht, Chairman of Jaws, as well as commitments from funds affiliated with Fidelity Management & Research Company, funds and accounts managed by BlackRock, Third Point and Maverick Capital Cano Health provides value-based care for more than 103,000 members through its network of 564 primary care physicians across 14 markets in Florida, Texas, Nevada and Puerto Rico. The Company is expected to receive up to $935 million in transaction proceeds to pay down debt and provide growth capital, and a substantial majority of up to $465 million of proceeds is expected to be allocated to Cano Health's financial sponsor. The transaction is expected to close at the end of the first quarter or the beginning of the second quarter of 2021. finance.yahoo.com
J
by AlenCiken
Air T, Inc. Announces Intent to Form New Aircraft Equity VehicleAir T, Inc. Announces Intent to Form New Aircraft Equity Vehicle AIRT) announced today that it has entered into letters of intent with three separate, large investment and asset management firms (the "Investors") to form a new aircraft asset management business to be called Contrail Aircraft Management ("CAM"), and a new aircraft capital joint venture to be called Contrail Fund II ("CFII"). The parties presently expect the new business and joint venture to be formed and capitalized by the end of January 2021. The new business and joint venture are being formed to purchase and sell aircraft and engines to be relet or disassembled and sold for parts. The parties anticipate that CFII will be capitalized initially with approximately $108,000,000 in equity capital and that it will establish a portfolio of aircraft assets, focusing on whole aircraft and engine acquisitions, sale-leaseback transactions and end of life part-out solutions. The capital contributed by the Investors -- presently anticipated to be approximately $100,000,000 -- will be contributed into CFII. The Upsize Commitment is anticipated to exceed $250,000,000. Contrail intends to contribute approximately $8,000,000 of the initial capital committed to the fund as well, which is anticipated to lead to returns alongside the other investors. finance.yahoo.com
NASDAQ:AIRT
by AlenCiken
Will the run for Run continue?SunRun and many other solar stocks have had incredible performance over the course of this year. Heading into 2021 the sector will surely be in the spotlight. Run has recently begin to show signs of continuing back toward recent highs. New volume has remained positive and price has broken out above its recent range. If the 61 area holds there could be a further move toward 82. If 61 doesn't hold then there is a potential retest of 49 in the cards. Please comment or ask any questions that come to mind
NASDAQ:RUN
by IngenuityTrading
PLTR headed for a run within next 4 weeks.....PLTR is headed for a run within the next 4 weeks.... with very little history and data the chart looks to have all its important support lines up high closer to is current pricing. After riding the top side of the BolBand's it has snapped down and up and appears to be coiling. the BB's are closing in for a pinch before years end. Looking for PLTR to run to 34 by Jan 22nd 2021. the move here is to buy shares and sell calls against those shares for premium bi weekly. keeping well safe of the growth line.
PLong
by TheStockMarketSniper
1
Eos Energy Secures Contract valued at $2 millionEos Energy Secures Contract to provide Safe, Sustainable Storage to California Hospital Eos Energy Enterprises, Inc. (NASDAQ: EOSE) (“Eos”), today announced it has a firm order from Charge Bliss, Inc. (“CBI”), a renewable energy microgrid developer/builder, to provide a critical care hospital with 2 MW of energy storage using its Znyth® battery. The deal is valued at $2 million. “We are proud to collaborate with Charge Bliss to provide safe and reliable storage for a hospital micro grid application,” Eos will provide this groundbreaking project with up to 2 MW of continuous power delivery upon installation, which is scheduled to take place in the second quarter of 2021. “Our microgrid systems are engineered to supply clean energy while reducing peak demand,” finance.yahoo.com
NASDAQ:EOSE
by AlenCiken
Expected net revenue increasedFourth quarter 2020 net revenue is expected to be approximately $3.5 million, increased from the prior expectation of approximately $2.5 million Received communication from the FDA explaining the reallocation of agency resources to address Emergency Use Authorization (EUA) applications for products related to the COVID-19 public health emergency is affecting marketing application reviews, including the Eversense 180-day product, which will be delayed by at least 60 days. This is consistent with what Senseonics understands other medical technology companies have reported. Inclusion of Eversense Category III CPT codes in the Centers for Medicare & Medicaid Services (CMS) 2021 Physician Fee Schedule (PFS), establishing global payment for the device cost and procedure fees for healthcare providers across the United States Full year 2021 net revenue is expected to be between $12 and $15 million, based on installed base, acceleration of Ascensia’s commercial activities and other factors Reached agreement with Roche to facilitate transition of distribution to Ascensia, as Roche sales conclude January 31, 2021, including final purchases, transition support activities, and resolution of other matters Highbridge second lien loan extinguished through completed conversion of their second lien debt to common stock, simplifying capital structure "Strong fourth quarter performance was driven by sales in Europe and supported by Ascensia’s initial US sales." We remain confident that the PROMISE study demonstrates that the excellent performance of the current Eversense system is extended for up to 180 days, and that there still is potential for a decision from the agency by the end of the end of the second quarter finance.yahoo.com
AMEX:SENS
by AlenCiken
1
ION Acquisition Soars on Taboola SPAC Merger RumorsION Acquisition Soars on Taboola SPAC Merger Rumors IACA stock’s October initial public offering raised $225 million for the special purpose acquisition company (SPAC) focusing on the Middle East region. Its stated goal was a merger with a private company valued at more than $1 billion. That IPO was upsized by more than 10% to 22.5 million units ahead of the floatation. Both ION and Taboola are based in Israel. Daily Haaretz reported on Monday that Taboola was mulling either a SPAC merger or its own IPO. Its sister publication, business daily TheMarker, on Tuesday reported the ION-Taboola negotiations. investorplace.com
I
by AlenCiken
Ouster to Combine With Colonnade Acquisition CorpOuster, a Leading Provider of High-Performance Digital Lidar Sensors, to Combine With Colonnade Acquisition Corp. to Accelerate Digital Lidar Adoption in Industrial, Smart Infrastructure, Robotics, and Automotive Markets. Transaction expected to provide up to $300 million in gross proceeds, comprised of Colonnade Acquisition Corp.’s $200 million of cash held in trust (assuming no redemptions) and a $100 million fully committed common stock PIPE at $10.00 per share, including from Ouster’s existing investors, Cox Enterprises, Fontinalis Partners, and WWJr Enterprises. Pro forma implied enterprise value of ~$1.6 billion and fully diluted pro forma equity value of ~$1.9 billion Ouster shareholders will roll 100% of their equity holdings into the combined company The boards of directors of both Ouster and Colonnade have unanimously approved the proposed business combination, which is expected to be completed in the first half of 2021, subject to, among other things, the approval by Colonnade's shareholders and Ouster’s shareholders, satisfaction of the minimum cash condition, which is equal to the $100 million committed common stock PIPE investment at $10.00 per share obtained in connection with the entry into the Merger Agreement, and certain other customary closing conditions stated in the Merger Agreement. www.businesswire.com
C
by AlenCiken